CN Stock MarketDetailed Quotes

Beijing Science Sun Pharmaceutical (300485)

Watchlist

9.11
-0.01-0.11%

Market Closed May 22 15:00 CST

4.39BMarket Cap-211.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Science Sun Pharmaceutical (300485) Balance Sheet

All

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

Assets

Current assets

Money funds

126.56%134.46M

17.10%88.13M

-16.19%90.81M

7.59%76.61M

-52.99%59.35M

-37.37%75.26M

-46.27%108.35M

-67.26%71.2M

-38.48%126.24M

-46.88%120.16M

Transactional financial assets

-3.83%1.49B

-1.50%1.47B

10.09%1.56B

35.86%1.55B

40.35%1.55B

42.05%1.5B

59.65%1.42B

33.61%1.14B

19.56%1.1B

17.65%1.05B

Notes receivable and accounts receivable

-4.57%40.51M

-11.58%44.87M

-14.94%47.8M

-21.46%44.44M

-19.78%42.45M

-3.17%50.75M

-17.46%56.19M

-16.70%56.59M

-33.41%52.91M

-38.16%52.42M

-Notes receivable

-26.87%1.58M

-27.85%2.48M

-45.13%2.54M

0.60%3.96M

-50.88%2.16M

-37.19%3.43M

-25.30%4.62M

-41.01%3.94M

-57.00%4.4M

-37.76%5.46M

-Accounts receivable

-3.38%38.93M

-10.40%42.4M

-12.23%45.26M

-23.11%40.48M

-16.96%40.29M

0.79%47.32M

-16.67%51.57M

-14.05%52.65M

-29.93%48.52M

-38.21%46.95M

Other receivables (including interest and dividends)

-11.29%987.73K

-33.90%948.16K

-13.26%988K

-25.09%992.09K

-75.36%1.11M

-64.27%1.43M

-72.99%1.14M

-68.20%1.32M

4.34%4.52M

-1.60%4.01M

-Other receivable

----

-25.09%992.09K

----

-64.27%1.43M

----

-68.20%1.32M

----

-1.60%4.01M

Advance payment

94.10%133.18K

-84.89%19.71K

-91.10%451.3K

-88.73%388.03K

-40.46%68.62K

-97.56%130.46K

10.03%5.07M

-23.51%3.44M

-97.53%115.25K

41.08%5.35M

Inventories

-16.45%71.56M

-15.39%68.85M

-19.38%72.7M

-14.06%82.9M

-21.03%85.65M

-24.00%81.37M

-16.86%90.18M

-2.78%96.45M

11.29%108.46M

20.17%107.06M

Other current assets

515.05%17.05M

70.31%10.8M

-55.79%3.31M

-23.70%7.4M

-65.60%2.77M

-40.43%6.34M

-7.83%7.48M

13.88%9.7M

-52.21%8.06M

-37.81%10.65M

Total current assets

0.81%1.75B

-1.41%1.69B

5.39%1.78B

27.78%1.76B

23.94%1.74B

26.50%1.71B

31.45%1.69B

9.88%1.38B

5.45%1.4B

2.47%1.35B

Non Current assets

Other non-current financial assets

-12.67%222.65M

-11.07%223.65M

-8.67%233.84M

-56.07%239.78M

-47.21%254.96M

-60.20%251.48M

-65.62%256.03M

-30.63%545.82M

-14.06%482.98M

10.91%631.81M

Long-term equity investment

-9.71%652.17M

0.45%709.58M

-1.22%711.1M

-2.74%707.67M

2.81%722.28M

-12.02%706.4M

-13.64%719.91M

-18.50%727.61M

-14.28%702.52M

-3.22%802.91M

Fixed assets

----

-8.80%455.08M

----

-8.42%476.95M

----

-7.22%499.01M

----

-6.91%520.79M

Constru in process

----

707.51%11.05M

----

953.18%11.03M

----

183.87%1.37M

----

219.82%1.05M

Productive biological assets

91.04%13.69M

96.38%13.76M

8.75%7.46M

22.61%7.3M

16.47%7.16M

26.64%7.01M

20.10%6.86M

2.45%5.95M

--6.15M

--5.53M

Intangible assets

-4.35%44.05M

-5.18%44.68M

-7.92%44.16M

-5.47%45.23M

-5.84%46.05M

-5.67%47.12M

-5.76%47.96M

-7.43%47.84M

-7.24%48.91M

-7.12%49.95M

Development expenditure

24.37%369.17M

25.35%366.91M

28.74%336.23M

29.28%320.55M

41.75%296.83M

40.07%292.71M

29.29%261.17M

27.47%247.95M

12.33%209.4M

13.53%208.97M

Goodwill

0.00%21.87M

Deferred tax assets

42.29%2.17M

27.69%2.28M

-19.22%1.89M

-16.78%1.96M

-39.50%1.52M

-26.24%1.79M

-55.69%2.34M

-56.24%2.35M

-44.81%2.52M

-54.52%2.42M

Usufruct assets

-3.02%11.26M

-3.00%11.34M

-3.51%11.43M

-3.49%11.52M

-2.93%11.61M

-2.91%11.69M

-2.35%11.85M

-2.33%11.93M

-2.85%11.96M

-2.83%12.04M

Other non current assets

174.05%32.85M

204.74%37.06M

-93.48%730.59K

7.08%12.21M

4.66%11.99M

3.15%12.16M

-2.40%11.21M

-1.37%11.4M

4.18%11.45M

-2.75%11.79M

Total non current assets

-1.99%1.81B

2.21%1.88B

-0.22%1.82B

-13.61%1.83B

-7.83%1.85B

-18.90%1.84B

-24.42%1.83B

-15.78%2.12B

-9.50%2.01B

0.91%2.27B

Total assets

-0.63%3.57B

0.47%3.57B

2.47%3.6B

2.70%3.6B

5.23%3.59B

-1.94%3.55B

-5.03%3.52B

-7.25%3.5B

-3.90%3.41B

1.49%3.62B

Liabilities

Current liabilities

Short term loan

--19.68M

--19.86M

--19.99M

----

Transactional financial liabilities

--127.83K

----

Notes payable and accounts payable

3.04%12.7M

43.91%22.63M

20.69%13.87M

77.84%19.75M

-24.74%12.32M

3.92%15.72M

10.30%11.49M

-2.73%11.11M

-23.32%16.37M

-29.97%15.13M

-Accounts payable

3.04%12.7M

43.91%22.63M

20.69%13.87M

77.84%19.75M

-24.74%12.32M

3.92%15.72M

10.30%11.49M

-2.73%11.11M

-23.32%16.37M

-29.97%15.13M

Contract liabilities

5.70%7.13M

-12.70%4.32M

-12.16%5.64M

16.12%6.55M

31.61%6.74M

-18.57%4.95M

-0.86%6.42M

0.94%5.64M

-40.14%5.12M

-30.65%6.08M

Advance receipts

66.06%585.02K

70.51%600.71K

----

--352.29K

0.00%352.29K

----

0.00%352.29K

Salaries payable

-8.10%4.3M

-18.12%4.32M

-6.15%4.26M

1.29%4.61M

-4.75%4.68M

10.85%5.27M

-14.18%4.54M

-17.25%4.55M

-14.60%4.92M

-8.65%4.76M

Taxs payable

-72.97%2.52M

-75.31%1.99M

124.86%4.78M

91.97%4.2M

252.55%9.32M

501.35%8.08M

15.30%2.13M

-28.82%2.19M

-22.21%2.64M

-58.94%1.34M

Other payable (including interest and dividends)

0.49%39.56M

-19.18%38.02M

-43.82%32.41M

-18.41%40.89M

5.20%39.36M

104.57%47.04M

326.43%57.69M

122.97%50.12M

143.52%37.42M

-33.52%22.99M

-Other payable

----

-18.41%40.89M

----

104.57%47.04M

----

122.97%50.12M

----

-33.52%22.99M

Other current liabilities

-34.29%575.84K

-32.61%430.9K

-12.16%733.59K

16.12%851.4K

31.61%876.38K

-19.13%639.43K

-0.86%835.17K

0.94%733.21K

-40.14%665.87K

-30.65%790.65K

Total current liabilities

18.35%87.17M

12.48%92.3M

-1.71%81.68M

3.39%76.85M

9.71%73.66M

59.49%82.05M

116.41%83.11M

52.38%74.33M

20.88%67.14M

-31.34%51.45M

Current liabilities

Deferred tax liabilities

-8.17%82.02M

0.06%83.24M

9.82%88.14M

11.06%89.26M

31.73%89.32M

-19.37%83.18M

-20.44%80.25M

-25.05%80.37M

-16.46%67.81M

25.56%103.16M

Long term deferred income

-44.36%680.72K

-66.15%420.72K

--1.44M

--1.16M

--1.22M

--1.24M

----

Total non current liabilities

-8.66%82.71M

-0.91%83.66M

11.61%89.57M

12.50%90.42M

33.53%90.54M

-18.16%84.43M

-20.44%80.25M

-25.05%80.37M

-16.46%67.81M

25.56%103.16M

Total liabilities

3.46%169.88M

5.69%175.95M

4.83%171.26M

8.12%167.27M

21.68%164.2M

7.68%166.48M

17.30%163.36M

-0.83%154.7M

-1.29%134.94M

-1.58%154.61M

Shareholders equity

Paid-in capital

0.00%481.67M

Capital reserve funds

0.00%845.93M

Surplus reserve funds

0.00%244.68M

Retained profit

-1.14%1.8B

0.82%1.8B

4.63%1.84B

4.81%1.83B

9.04%1.82B

-4.26%1.78B

-10.35%1.75B

-13.15%1.75B

-7.21%1.67B

3.42%1.86B

Other composite income

-75.29%346.44K

-48.67%746.76K

91.45%1.02M

14.32%1.3M

43.27%1.4M

58.64%1.45M

-61.89%534.61K

-30.30%1.14M

803.34%978.73K

181.85%917.04K

Shareholders equity without minority interests

-0.64%3.38B

0.41%3.37B

2.46%3.41B

2.54%3.4B

4.67%3.4B

-2.30%3.36B

-5.76%3.33B

-7.39%3.32B

-3.82%3.25B

1.84%3.44B

Minority interests

-24.25%20.63M

-24.00%21.47M

-9.51%24.95M

-7.87%26.22M

-8.77%27.23M

-10.52%28.26M

-20.89%27.57M

-20.86%28.46M

-20.76%29.85M

-17.09%31.58M

Total shareholder equity

-0.83%3.4B

0.21%3.39B

2.36%3.43B

2.45%3.43B

4.55%3.42B

-2.37%3.39B

-5.91%3.35B

-7.52%3.35B

-4.00%3.28B

1.63%3.47B

Total liabilityies and equity

-0.63%3.57B

0.47%3.57B

2.47%3.6B

2.70%3.6B

5.23%3.59B

-1.94%3.55B

-5.03%3.52B

-7.25%3.5B

-3.90%3.41B

1.49%3.62B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

PwC China (Special General Partnership)

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023
Assets
Current assets
Money funds	126.56%134.46M	17.10%88.13M	-16.19%90.81M	7.59%76.61M	-52.99%59.35M	-37.37%75.26M	-46.27%108.35M	-67.26%71.2M	-38.48%126.24M	-46.88%120.16M
Transactional financial assets	-3.83%1.49B	-1.50%1.47B	10.09%1.56B	35.86%1.55B	40.35%1.55B	42.05%1.5B	59.65%1.42B	33.61%1.14B	19.56%1.1B	17.65%1.05B
Notes receivable and accounts receivable	-4.57%40.51M	-11.58%44.87M	-14.94%47.8M	-21.46%44.44M	-19.78%42.45M	-3.17%50.75M	-17.46%56.19M	-16.70%56.59M	-33.41%52.91M	-38.16%52.42M
-Notes receivable	-26.87%1.58M	-27.85%2.48M	-45.13%2.54M	0.60%3.96M	-50.88%2.16M	-37.19%3.43M	-25.30%4.62M	-41.01%3.94M	-57.00%4.4M	-37.76%5.46M
-Accounts receivable	-3.38%38.93M	-10.40%42.4M	-12.23%45.26M	-23.11%40.48M	-16.96%40.29M	0.79%47.32M	-16.67%51.57M	-14.05%52.65M	-29.93%48.52M	-38.21%46.95M
Other receivables (including interest and dividends)	-11.29%987.73K	-33.90%948.16K	-13.26%988K	-25.09%992.09K	-75.36%1.11M	-64.27%1.43M	-72.99%1.14M	-68.20%1.32M	4.34%4.52M	-1.60%4.01M
-Other receivable	----	----	----	-25.09%992.09K	----	-64.27%1.43M	----	-68.20%1.32M	----	-1.60%4.01M
Advance payment	94.10%133.18K	-84.89%19.71K	-91.10%451.3K	-88.73%388.03K	-40.46%68.62K	-97.56%130.46K	10.03%5.07M	-23.51%3.44M	-97.53%115.25K	41.08%5.35M
Inventories	-16.45%71.56M	-15.39%68.85M	-19.38%72.7M	-14.06%82.9M	-21.03%85.65M	-24.00%81.37M	-16.86%90.18M	-2.78%96.45M	11.29%108.46M	20.17%107.06M
Other current assets	515.05%17.05M	70.31%10.8M	-55.79%3.31M	-23.70%7.4M	-65.60%2.77M	-40.43%6.34M	-7.83%7.48M	13.88%9.7M	-52.21%8.06M	-37.81%10.65M
Total current assets	0.81%1.75B	-1.41%1.69B	5.39%1.78B	27.78%1.76B	23.94%1.74B	26.50%1.71B	31.45%1.69B	9.88%1.38B	5.45%1.4B	2.47%1.35B
Non Current assets
Other non-current financial assets	-12.67%222.65M	-11.07%223.65M	-8.67%233.84M	-56.07%239.78M	-47.21%254.96M	-60.20%251.48M	-65.62%256.03M	-30.63%545.82M	-14.06%482.98M	10.91%631.81M
Long-term equity investment	-9.71%652.17M	0.45%709.58M	-1.22%711.1M	-2.74%707.67M	2.81%722.28M	-12.02%706.4M	-13.64%719.91M	-18.50%727.61M	-14.28%702.52M	-3.22%802.91M
Fixed assets	----	----	----	-8.80%455.08M	----	-8.42%476.95M	----	-7.22%499.01M	----	-6.91%520.79M
Constru in process	----	----	----	707.51%11.05M	----	953.18%11.03M	----	183.87%1.37M	----	219.82%1.05M
Productive biological assets	91.04%13.69M	96.38%13.76M	8.75%7.46M	22.61%7.3M	16.47%7.16M	26.64%7.01M	20.10%6.86M	2.45%5.95M	--6.15M	--5.53M
Intangible assets	-4.35%44.05M	-5.18%44.68M	-7.92%44.16M	-5.47%45.23M	-5.84%46.05M	-5.67%47.12M	-5.76%47.96M	-7.43%47.84M	-7.24%48.91M	-7.12%49.95M
Development expenditure	24.37%369.17M	25.35%366.91M	28.74%336.23M	29.28%320.55M	41.75%296.83M	40.07%292.71M	29.29%261.17M	27.47%247.95M	12.33%209.4M	13.53%208.97M
Goodwill	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M
Deferred tax assets	42.29%2.17M	27.69%2.28M	-19.22%1.89M	-16.78%1.96M	-39.50%1.52M	-26.24%1.79M	-55.69%2.34M	-56.24%2.35M	-44.81%2.52M	-54.52%2.42M
Usufruct assets	-3.02%11.26M	-3.00%11.34M	-3.51%11.43M	-3.49%11.52M	-2.93%11.61M	-2.91%11.69M	-2.35%11.85M	-2.33%11.93M	-2.85%11.96M	-2.83%12.04M
Other non current assets	174.05%32.85M	204.74%37.06M	-93.48%730.59K	7.08%12.21M	4.66%11.99M	3.15%12.16M	-2.40%11.21M	-1.37%11.4M	4.18%11.45M	-2.75%11.79M
Total non current assets	-1.99%1.81B	2.21%1.88B	-0.22%1.82B	-13.61%1.83B	-7.83%1.85B	-18.90%1.84B	-24.42%1.83B	-15.78%2.12B	-9.50%2.01B	0.91%2.27B
Total assets	-0.63%3.57B	0.47%3.57B	2.47%3.6B	2.70%3.6B	5.23%3.59B	-1.94%3.55B	-5.03%3.52B	-7.25%3.5B	-3.90%3.41B	1.49%3.62B
Liabilities
Current liabilities
Short term loan	--19.68M	--19.86M	--19.99M	----	----	----	----	----	----	----
Transactional financial liabilities	--127.83K	--127.83K	----	----	----	----	----	----	----	----
Notes payable and accounts payable	3.04%12.7M	43.91%22.63M	20.69%13.87M	77.84%19.75M	-24.74%12.32M	3.92%15.72M	10.30%11.49M	-2.73%11.11M	-23.32%16.37M	-29.97%15.13M
-Accounts payable	3.04%12.7M	43.91%22.63M	20.69%13.87M	77.84%19.75M	-24.74%12.32M	3.92%15.72M	10.30%11.49M	-2.73%11.11M	-23.32%16.37M	-29.97%15.13M
Contract liabilities	5.70%7.13M	-12.70%4.32M	-12.16%5.64M	16.12%6.55M	31.61%6.74M	-18.57%4.95M	-0.86%6.42M	0.94%5.64M	-40.14%5.12M	-30.65%6.08M
Advance receipts	66.06%585.02K	70.51%600.71K	----	----	--352.29K	0.00%352.29K	----	----	----	0.00%352.29K
Salaries payable	-8.10%4.3M	-18.12%4.32M	-6.15%4.26M	1.29%4.61M	-4.75%4.68M	10.85%5.27M	-14.18%4.54M	-17.25%4.55M	-14.60%4.92M	-8.65%4.76M
Taxs payable	-72.97%2.52M	-75.31%1.99M	124.86%4.78M	91.97%4.2M	252.55%9.32M	501.35%8.08M	15.30%2.13M	-28.82%2.19M	-22.21%2.64M	-58.94%1.34M
Other payable (including interest and dividends)	0.49%39.56M	-19.18%38.02M	-43.82%32.41M	-18.41%40.89M	5.20%39.36M	104.57%47.04M	326.43%57.69M	122.97%50.12M	143.52%37.42M	-33.52%22.99M
-Other payable	----	----	----	-18.41%40.89M	----	104.57%47.04M	----	122.97%50.12M	----	-33.52%22.99M
Other current liabilities	-34.29%575.84K	-32.61%430.9K	-12.16%733.59K	16.12%851.4K	31.61%876.38K	-19.13%639.43K	-0.86%835.17K	0.94%733.21K	-40.14%665.87K	-30.65%790.65K
Total current liabilities	18.35%87.17M	12.48%92.3M	-1.71%81.68M	3.39%76.85M	9.71%73.66M	59.49%82.05M	116.41%83.11M	52.38%74.33M	20.88%67.14M	-31.34%51.45M
Current liabilities
Deferred tax liabilities	-8.17%82.02M	0.06%83.24M	9.82%88.14M	11.06%89.26M	31.73%89.32M	-19.37%83.18M	-20.44%80.25M	-25.05%80.37M	-16.46%67.81M	25.56%103.16M
Long term deferred income	-44.36%680.72K	-66.15%420.72K	--1.44M	--1.16M	--1.22M	--1.24M	----	----	----	----
Total non current liabilities	-8.66%82.71M	-0.91%83.66M	11.61%89.57M	12.50%90.42M	33.53%90.54M	-18.16%84.43M	-20.44%80.25M	-25.05%80.37M	-16.46%67.81M	25.56%103.16M
Total liabilities	3.46%169.88M	5.69%175.95M	4.83%171.26M	8.12%167.27M	21.68%164.2M	7.68%166.48M	17.30%163.36M	-0.83%154.7M	-1.29%134.94M	-1.58%154.61M
Shareholders equity
Paid-in capital	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M
Capital reserve funds	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M
Surplus reserve funds	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M
Retained profit	-1.14%1.8B	0.82%1.8B	4.63%1.84B	4.81%1.83B	9.04%1.82B	-4.26%1.78B	-10.35%1.75B	-13.15%1.75B	-7.21%1.67B	3.42%1.86B
Other composite income	-75.29%346.44K	-48.67%746.76K	91.45%1.02M	14.32%1.3M	43.27%1.4M	58.64%1.45M	-61.89%534.61K	-30.30%1.14M	803.34%978.73K	181.85%917.04K
Shareholders equity without minority interests	-0.64%3.38B	0.41%3.37B	2.46%3.41B	2.54%3.4B	4.67%3.4B	-2.30%3.36B	-5.76%3.33B	-7.39%3.32B	-3.82%3.25B	1.84%3.44B
Minority interests	-24.25%20.63M	-24.00%21.47M	-9.51%24.95M	-7.87%26.22M	-8.77%27.23M	-10.52%28.26M	-20.89%27.57M	-20.86%28.46M	-20.76%29.85M	-17.09%31.58M
Total shareholder equity	-0.83%3.4B	0.21%3.39B	2.36%3.43B	2.45%3.43B	4.55%3.42B	-2.37%3.39B	-5.91%3.35B	-7.52%3.35B	-4.00%3.28B	1.63%3.47B
Total liabilityies and equity	-0.63%3.57B	0.47%3.57B	2.47%3.6B	2.70%3.6B	5.23%3.59B	-1.94%3.55B	-5.03%3.52B	-7.25%3.5B	-3.90%3.41B	1.49%3.62B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	PwC China (Special General Partnership)	--	--	--	PwC China (Special General Partnership)	--	--	--	PwC China (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Middle East conflict spreads to the stock market! How should investors respond?

On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm